Feed / WRBY

Warby Parker Inc.

WRBY

Healthcare · 24.72 +1.7% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:55 GMT-4

Market read

Warby Parker Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 6 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Company+1.7% todayVolume comparison unavailable
Market group0 of 6 activeGrowth-Oriented Stocks · unavailable
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • IEEPA tariff refunds contributed to the latest three-month gross-profit increase, leaving the size and recurrence of that benefit to compare in later filings.
  • Company reports selective price increases implemented in Q2 2025 that contributed to Average Revenue per Customer growth.

Invalidation: The isolated read changes if WRBY's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Instruments & Supplies

No new filing conclusion is available. 0 of 6 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • IEEPA tariff refunds contributed to the latest three-month gross-profit increase, leaving the size and recurrence of that benefit to compare in later filings.
  • Company reports selective price increases implemented in Q2 2025 that contributed to Average Revenue per Customer growth.

Company research

Understand the business, not just the ticker

As of Sep 12, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods7
Price observations328
Usable filing statements107
Verified relationships4
Evidence supporting the case
  • Latest annual revenue changed +13.0% year over year.
  • Operating margin changed +3.3 percentage points in the latest annual period.
  • Net margin changed +2.8 percentage points in the latest annual period.
  • Operating cash flow covered net income at 67.51x in the latest annual period.
  • Macroeconomic conditions has repeated favorable evidence across 5 filings.
  • Pricing and mix has repeated favorable evidence across 4 filings.
Evidence challenging the case
  • Diluted shares increased 3.9% in the latest annual period.
Questions before a position
  • P/E is 6456% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 11, 2026

24.72
6m+5.1%12m-8.5%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$540.8M+37.4%$-2.21+34.3%
2022-12-31$598.1M+10.6%$-0.96
2023-12-31$669.8M+12.0%$-0.54+2.1%
2024-12-31$771.3M+15.2%$-0.17+2.6%
2025-12-31$871.9M+13.0%$0.01+3.9%

What management says matters

Persistent and emerging business drivers

Demand and volumemixed · 5 filings
We expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting demand, the cost and management of inventory, tariffs, shipping costs, laboratory utilization, and the scaling of our…
10-Q · Aug 6, 2026
Foreign exchangemixed · 5 filings
Revenue and income generated by our operations in Canada and our foreign denominated cost of goods sold are impacted by changes in foreign currency exchange rates.
10-Q · Aug 6, 2026
Macroeconomic conditionspositive · 5 filings
We expect SG&A to increase in absolute dollars over time and to fluctuate as a percentage of revenue due to the anticipated growth of our business, intentional investments in marketing, and changing prices of goods and services caused by inflation and other m…
10-Q · Aug 6, 2026
Pricing and mixpositive · 4 filings
These impacts were partially offset by selective price increases implemented 27 Table of Contents during the second quarter of 2025, and increased penetration of higher margin progressive lenses and other lens enhancements.
10-Q · May 7, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 3.5× · EV/sales 3.2×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

24.72+1.7% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for WRBY. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for WRBY. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind WRBY

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

JPMJPMorgan Chase & Co.lenderMay 7, 2026

2024 Credit Facility In February 2024, the Borrowers entered into a Credit Agreement with JPMorgan Chase Bank, N.A.

AFRMAffirm Holdings, Inc.supplierFeb 26, 2026

We rely on third parties, including Stripe, Inc., Affirm, Inc., and PayPal Holdings, Inc.

PYPLPayPal Holdings, Inc.supplierFeb 26, 2026

We rely on third parties, including Stripe, Inc., Affirm, Inc., and PayPal Holdings, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

WRBY is currently a Follower in the organic co-movement group Growth-Oriented Stocks. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.